ITGAV expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.148800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.581600E-01
Normal-vs-Stage2
2.607400E-01
Normal-vs-Stage3
2.424800E-01
Normal-vs-Stage4
9.640600E-01
Stage1-vs-Stage2
1.832620E-01
Stage1-vs-Stage3
9.496000E-01
Stage1-vs-Stage4
8.152500E-02
Stage2-vs-Stage3
2.959400E-01
Stage2-vs-Stage4
2.316200E-01
Stage3-vs-Stage4
1.605630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.873580E-01
Normal-vs-AfricanAmerican
6.969600E-01
Normal-vs-Asian
1.456430E-01
Caucasian-vs-AfricanAmerican
3.712200E-01
Caucasian-vs-Asian
3.829000E-01
AfricanAmerican-vs-Asian
2.166000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.201400E-01
Normal-vs-Female
2.408400E-01
Male-vs-Female
7.697800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.857200E-01
Normal-vs-Age(41-60Yrs)
6.308600E-01
Normal-vs-Age(61-80Yrs)
1.148570E-01
Normal-vs-Age(81-100Yrs)
3.518600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.757000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.645200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.836800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.009700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.808900E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.365200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.001800E-01
Normal-vs-Daily Drinker
3.607400E-01
Normal-vs-Weekly Drinker
5.085200E-01
Normal-vs-Occasional Drinker
5.562600E-01
Normal-vs-Social Drinker
5.666600E-01
Non Drinker-vs-Daily Drinker
2.548400E-01
Non Drinker-vs-Weekly Drinker
8.159400E-01
Non Drinker-vs-Occasional Drinker
2.374400E-01
Non Drinker-vs-Social Drinker
3.077800E-01
Daily Drinker-vs-Weekly Drinker
1.390840E-01
Daily Drinker-vs-Occasional Drinker
4.098100E-02
Daily Drinker-vs-Social Drinker
8.346200E-02
Weekly Drinker-vs-Occasional Drinker
3.777000E-01
Weekly Drinker-vs-Social Drinker
4.434800E-01
Occasional Drinker-vs-Social Drinker
9.525400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.841800E-01
Normal-vs-Grade 2
5.902200E-02
Normal-vs-Grade 3
9.800000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.242300E-02
Grade 1-vs-Grade 3
1.128040E-02
Grade 1-vs-Grade 4
3.841800E-01
Grade 2-vs-Grade 3
1.013040E-01
Grade 2-vs-Grade 4
5.902200E-02
Grade 3-vs-Grade 4
9.800000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.440750E-01
Normal-vs-NonDiabetic
1.959620E-01
Diabetic-vs-NonDiabetic
5.490000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.186000E-01
Normal-vs-NoPancreatitis
2.081200E-01
Pancreatitis-vs-NoPancreatitis
3.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.578210E-01
Normal-vs-N1
2.719000E-01
N0-vs-N1
5.121900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.274400E-01
Normal-vs-TP53-NonMutant
7.442500E-02
TP53-Mutant-vs-TP53-NonMutant
4.738600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
